SenzaGen
SenzaGen: OECD Approval for GARDskin (Redeye)

2022-06-30 11:37
Redeye embraces the news regarding the OECD validation on GARDskin. We believe this is an important step for SenzaGen and that the approval will significantly affect the demand for GARDskin. This was expected from our point of view, and we reiterate our Base Case of SEK 16.

info@redeye.se (Redeye.se)
Redeye AB - Redeye.se

SenzaGen - I dag

{point.key}

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex

Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor

Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor

Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror

Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -